Try our beta test site

Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months

This study has been completed.
Novartis Vaccines
Information provided by (Responsible Party):
Novartis Identifier:
First received: March 25, 2008
Last updated: December 7, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)